News for Aytu Biopharma, Inc. (0A8M.L)

Release Date: February 12, 2025For the complete transcript of the earnings call, please refer to the full earnings call transcript. Positive Points Aytu BioPhar

Refinitiv StreetEvents Event TranscriptE D I T E D V E R S I O NAYTU.OQ - Aytu Biopharma IncQ2 2025 Aytu Biopharma Inc Earnings CallFeb 12, 2025 / 09:30PM GMT

Net income of $0.8 millionAdjusted EBITDA1 of $1.3 millionPediatric Portfolio net revenue up 86% sequentiallyFirst quarterly sequential prescription increase fo

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q2 2025 Earnings Conference Call February 12, 2025 4:30 PM ETCompany ParticipantsRobert Blum - Investor Relations, Lytham...

Ironwood Pharmaceuticals (IRWD) recently experienced a significant stock price drop of 5.20%, bringing its share price to $3.58. The trading volume reached 431,

DENVER, CO / ACCESSWIRE / January 6, 2025 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing no

DENVER, CO / ACCESSWIRE / December 3, 2024 / SUMMARY NOTICE OF PENDENCY OF DERIVATIVE ACTION, AGREEMENT OF SETTLEMENT AND RELEASE WITH RESPECT TO CERTAIN PARTIE

DENVER, CO / ACCESSWIRE / November 22, 2024 / Aytu BioPharma, Inc. (the "Company" or "Aytu") (Nasdaq:AYTU), a pharmaceutical company focused on commercializing

Aytu BioPharma, Inc. (NASDAQ:AYTU) Q1 2025 Earnings Conference Call November 13, 2024 4:30 PM ETCompany ParticipantsRobert Blum - IR, Lytham PartnersJosh...

Ironwood Pharmaceuticals (IRWD) experienced a notable stock surge with shares rising by 5.01%. The stock was last reported at $4.40 per share with a trading vol

According to Research by SNS Insider, Over-The-Counter (OTC) Drugs Market Growth is Driven by Rising Consumer Awareness, Growth of Lifestyle Diseases, and...

Earnings call: Aytu BioPharma achieves first positive operating income

Shares of Shapeways Holdings, Inc. (NASDAQ: SHPW) tumbled during Wednesday’s session following downbeat results.

/PRNewswire/ -- The "Global Attention Deficit Hyperactivity Disorder (ADHD) Treatment Market Report and Forecast 2023-2031" report has been added to...

Short squeeze penny stocks to watch this month.

Results from 3 major testosterone trials are expected in 2023. Read more to see why I think AbbVie and ANI are best positioned to benefit from this.

Start Time: 16:30 End Time: 17:12 Aytu BioPharma, Inc.

Altimmune Appoints Richard Eisenstadt as Chief Financial Officer GAITHERSBURG, MD, -- December 13, 2021 -- Altimmune, Inc. , a clinical-stage biopharmaceutical company focused... | December 13, 2021

(RTTNews) - Biopharmaceutical company Altimmune, Inc. (ALT) announced Monday the appointment of Richard Eisenstadt as Chief Financial Officer, eff...